Israeli heart medical device co Innoventric raises $28.5m

Innoventric lead team credit: Eyal Toueg
Innoventric lead team credit: Eyal Toueg

The company has developed a device for the treatment of transcatheter tricuspid regurgitation (TR) using a revolutionary cross-caval technology.

Israeli heart medical device company Innoventric today announced the completion of a $28.5 million Series B financing round. The company has developed a device for the treatment of transcatheter tricuspid regurgitation (TR) using a revolutionary cross-caval technology.

This latest financing round, which was led by RA Capital Management, with participation of new investor the European Investment Committee (EIC) and existing investors BRM Group, JG Private Equity, and Mivtach Shamir Holdings, brings to $41 million the total amount raised by the company.

Innoventric has already successfully completed a first-in-human clinical trial in Europe, and performed many additional implantations, treating over 40 patients so far. Recently, the company received FDA clearance for an Early Feasibility Study (EFS) in the US, and patient enrollment is actively ongoing with the first US patients already treated. The funds raised will be used to advance clinical trials and expand regulatory approvals in the US and Europe.

Innoventric's device addresses tricuspid regurgitation, a severe condition that impairs the cardiac blood flow, by replacing the native valve's function through a heterotopic, cross-caval approach. With Innoventric, a prosthetic valve is anchored to the vena cava instead of the beating heart, so a complete seal is achieved without the risk of leakage or detachment. This method simplifies the implantation process and overcomes the anatomical complexities associated with traditional treatments. Positioned at the forefront of the $10 billion annual transcatheter heart valve replacement market, Innoventric's technology is poised to transform tricuspid valve treatment.

The Innoventric device offers significant advantages, including broad patient applicability. Designed to accommodate various anatomies, it enables treatment for patients who are typically ineligible for tricuspid procedures. Its innovative anchoring technique provides secure attachment to the tubular superior vena cava (SVC) and inferior vena cava (IVC) rather than the beating heart, which minimizes risks such as leakage or detachment. The device also supports a streamlined procedure, as it can be implanted quickly without the need for echocardiography or general anesthesia, significantly enhancing success rates and reducing patient recovery time.

Innoventric CEO Amir Danino said, "Our mission is to revolutionize tricuspid regurgitation care with minimally invasive therapies that significantly improve patient outcomes. The strong backing from our investors, coupled with the progress we've achieved, underscores the need and huge potential of our approach to treat TR."

RA Capital Management principal Anurag Kondapalli added, "We are excited to support Innoventric as it looks to transform the approach to TR treatment. The strong outcomes from their European first-in-human trial demonstrate the immense potential of their anatomy-agnostic device to treat a broader range of patients who have lacked viable options. We are very impressesd with Innoventric’s technology and leadership, and believe their solution has the potential to significantly reshape the future of TR care."

Published by Globes, Israel business news - en.globes.co.il - on October 29, 2024.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024.

Innoventric lead team credit: Eyal Toueg
Innoventric lead team credit: Eyal Toueg
Elon Musk credit: Shutterstock Elon Musk's SpaceX set to launch Israel's Dror satellite

The Dror satellite will serve Israel's communications needs for the next 15 years.

Maurice Ferre illustration Gil Gibli Insightec wins new FDA approval for Parkinson's treatment

The company's revenue is growing, but it is yet to post a profit. CEO Maurice Ferré: The market no longer tolerates losses.

Benny Landa  credit: Einat Levron Landa Digital Printing granted protection from creditors

The stay of proceedings is until the end of August. The company owes NIS 1.7 billion, mainly arising from investors' loans.

Beyond Towers Givatayim credit: Barely Levitzky Kassif architects Akamai in talks to lease 20,000-sq.m. in Givatayim tower

The US company wants to double the current size of its Tel Aviv office as part of its expansion in Israel.

Begin Highway cover Jerusalem credit: Dagan Visual Solutions Kolker Kolker Epstein Architects Jerusalem District C'ttee approves plan to cover Begin Highway

There will be intensive construction above the highway including some 2,000 housing units, 250 units for assisted living, 300 hotel rooms, 30,000 square meters office and commercial space, and 75,000 square meters for public use.

Shekel strengthening sharply credit: Tali Bogdanovsky with Adobe Firefly Shekel at strongest against dollar since April 2022

The record breaking stock market, falling risk premium, high interest rate, and geopolitical developments all support the continued strengthening of the shekel.

Intel fab construction credit: Intel Intel Kiryat Gat expansion frozen for foreseeable future

Amid Intel's financial woes, part of the $25 billion expansion in Israel has been halted while the other part, although completed, is not operational.

Nvidia Mevo Carmel development center credit: Assaf Gilead Mevo Carmel in pole position to house Nvidia Israel campus

Industry experts believe that the Mevo Carmel Science and Industry Park near Yokne'am is the favorite to persuade Nvidia to build its 180,000 square meter campus there.

Ben Gurion airport credit: Tali Bogdanovsky Foreign airlines returning to Israel faster than expected

United Airlines, Lufthansa Group, Wizz Air and Aegean will add dozens of new flights to Ben Gurion airport's departures and arrivals board over the summer and bring down fares.

New construction in Israel credit: Shutterstock Sharp fall in new home sales after restrictions imposed

The Bank of Israel's efforts to restrict developers financing offers saw housing sales record one of its weakest months in the past 25 years, the Finance Ministry reports.

Apple Vision Pro glasses credit: Apple Apple acquires Israeli 3D avatar co TrueMeeting

Apple will integrate TrueMeeting's technology into its Vision Pro smart glasses, which were launched last year.

Xiaomi SU7 credit: PR Israel to import Xiaomi cars

Xiaomi importer Hemilton has formed a joint partnership with the Hamizrahi vehicle importer to bring the Chinese electric vehicles to Israel.

Hermes 900 UAV credit: Elbit Systems Swiss mull cancelling $380m Elbit drone deal - report

"The technical problems with the surveillance drones are apparently so serious that they must be accompanied by a helicopter or another aircraft to avoid collisions," Swiss newspaper NZZ reports.

Yitzhak Tshuva credit: Gidon Levy and Tali Bogdanovsky BoI grants Tshuva permit to control Isracard

Yitzhak Tshuva's Delek Group will now buy 37% of the shares in credit card company Isracard, giving it a 40% stake.

Wizz Air  credit: Shutterstock/Peter Leczo Wizz Air to restart Tel Aviv flights in August

Wizz Air will gradually reintroduce Israel services, starting with flights from Tel Aviv to Larnaca and Budapest.

Zeekr 001  credit: Mobileye Intel selling 8% Mobileye stake

After the secondary offering, Intel will be left with an 80% holding in the Israeli advanced driving assistance systems company.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018